Signaling and apoptosis differences between severe hypoxia and desferoxamine treatment of human epithelial cells

Biochemistry and Cell Biology

Volumn 86, Issue 5, 2008, Pages 425-436

  Box, Adrian Harold ^a   Yuen, Carol ^a   Ponjevic, Dragana ^a   Fick, Gordon H ^b   Demetrick, Douglas James ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

AKT; Apoptosis; Cell cycle; Desferoxamine; Hypoxia

Indexed keywords

CELL CULTURE; CELL DEATH; CYTOLOGY; MATHEMATICAL MODELS; PROBABILITY DENSITY FUNCTION;

AKT; APOPTOSIS; CELL CYCLE; DESFEROXAMINE; HYPOXIA;

CELLS;

DEFEROXAMINE; PROTEIN KINASE B;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE SEVERITY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANOXIA; APOPTOSIS; CELL LINE; DEFEROXAMINE; ENZYME ACTIVATION; EPITHELIAL CELLS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; PROTEASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; SIDEROPHORES; SIGNAL TRANSDUCTION;

EID: 54249118338     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/O08-106     Document Type: Article

References (64)

1. Adachi, M., Katsumura, K.R., Fujii, K., Kobayashi, S., Aoki, H., and Matsuzaki, M. 2003. Proteasome-dependent decrease in Akt by growth factors in vascular smooth muscle cells. FEBS Lett. 554: 77-80. doi:10.1016/S0014- 5793(03)01109-8. PMID:14596918.
2. Alcantara, O., Kalidas, M., Baltathakis, I., and Boldt, D.H. 2001. Expression of multiple genes regulating cell cycle and apoptosis in differentiating hematopoietic cells is dependent on iron. Exp. Hematol. 29: 1060-1069. doi:10.1016/S0301-472X(01)00683-X. PMID:11532346.
3. Alvarez-Tejado, M., Naranjo-Suarez, S., Jimenez, C., Carrera, A.C., Landazuri, M.O., and del Peso, L. 2001. Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis. J. Biol. Chem. 276: 22368-22374. doi:10.1074/jbc.M011688200. PMID:11294857.
4. Amellem, O., and Pettersen, E.O. 1991. Cell inactivation and cell cycle inhibition as induced by extreme hypoxia: the possible role of cell cycle arrest as a protection against hypoxia-induced lethal damage. Cell Prolif. 24: 127-141. doi:10.1111/j.1365-2184.1991.tb01144.x. PMID:2009318.
5. Azad, M.B., Chen, Y., Henson, E.S., Cizeau, J., McMillan-Ward, E., Israels, S.J., et al. 2008. Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3. Autophagy, 4: 195-204. PMID:18059169.
6. Box, A.H., and Demetrick, D.J. 2004. Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines. Carcinogenesis, 25: 2325-2335. doi:10.1093/carcin/bgh274. PMID:15347600.
7. Brodie, C., Siriwardana, G., Lucas, J., Schleicher, R., Terada, N., Szepesi, A., et al. 1993. Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle. Cancer Res. 53: 3968-3975. PMID:8358725.
8. Chen, E.Y., Mazure, N.M., Cooper, J.A., and Giaccia, A.J. 2001. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation. Cancer Res. 61: 2429-2433. PMID:11289110.
9. Cho, D.H., Lee, H.J., Kim, H.J., Hong, S.H., Pyo, J.O., Cho, C., et al. 2007. Suppression of hypoxic cell death by APIP-induced sustained activation of AKT and ERK1/2. Oncogene, 26: 2809-2814. doi:10.1038/sj.onc.121008. PMID:17086211.
10. Comerford, K.M., Leonard, M.O., Cummins, E.P., Fitzgerald, K.T., Beullens, M., Bollen, M., and Taylor, C.T. 2006. Regulation of protein phosphatase 1γ activity in hypoxia through increased interaction with NIPP1: implications for cellular metabolism. J. Cell. Physiol. 209: 211-218. doi:10.1002/jcp.20726. PMID: 16826568.
11. Datta, S.R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M.E. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91: 231-241. doi:10.1016/S0092- 8674(00)80405-5. PMID:9346240.
12. Fan, L., Iyer, J., Zhu, S., Frick, K.K., Wada, R.K., Eskenazi, A.E., et al. 2001. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells. Cancer Res. 61: 1073-1079. PMID:11221835.
13. Fandrey, J., Frede, S., Ehleben, W., Porwol, T., Acker, H., and Jelkmann, W. 1997. Cobalt chloride and desferrioxamine antagonize the inhibition of erythropoietin production by reactive oxygen species. Kidney Int. 51: 492-496. doi:10.1038/ki.1997.68. PMID:9027728.
14. Gatenby, R.A., Kessler, H.B., Rosenblum, J.S., Coia, L.R., Moldofsky, P.J., Hartz, W.H., and Broder, G.J. 1988. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 14: 831-838. PMID:3360652.
15. Gleadle, J.M., Ebert, B.L., Firth, J.D., and Ratcliffe, P.J. 1995. Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am. J. Physiol. 268: C1362-C1368. PMID:7541940.
16. Green, S.L., Freiberg, R.A., and Giaccia, A.J. 2001. p21(Cip1) and p27(Kip1) regulate cell cycle re-entry after hypoxic stress but are not necessary for hypoxia-induced arrest. Mol. Cell. Biol. 21: 1196-1206. doi:10.1128/MCB.21.4.1196-1206.2001. PMID:11158306.
17. Guo, M., Song, L.P., Jiang, Y., Liu, W., Yu, Y., and Chen, G.Q. 2006. Hypoxia-mimetic agents desferrioxamine and cobalt chloride induce leukemic cell apoptosis through different hypoxia-inducible factor-1α independent mechanisms. Apoptosis, 11: 67-77. doi:10.1007/s10495-005-3085-3. PMID:16374551.
18. Hauck, L., Hansmann, G., Dietz, R., and von Harsdorf, R. 2002. Inhibition of hypoxia-induced apoptosis by modulation of retinoblastoma protein-dependent signaling in cardiomyocytes. Circ. Res. 91: 782-789. doi:10.1161/01.RES. 0000041030.98642.41. PMID:12411392.
19. Herscher, L.L., Krishna, M.C., Cook, J.A., Coleman, C.N., Biaglow, J.E., Tuttle, S.W., et al. 1994. Protection against SR 4233 (tirapazamine) aerobic cytotoxicity by the metal chelators desferrioxamine and tiron. Int. J. Radiat. Oncol. Biol. Phys. 30: 879-885. PMID:7960991.
20. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. U.S.A. 95: 7987-7992. doi:10.1073/pnas.95.14.7987. PMID:9653127.
21. 2 sensing. Science, 292: 464-468. doi:10.1126/science.1059817. PMID: 11292862.
22. 2-regulated prolyl hydroxylation. Science, 292: 468-472. doi:10.1126/science.1059796. PMID:11292861.
23. Kim, B.S., Yoon, K.H., Oh, H.M., Choi, E.Y., Kim, S.W., Han, W.C., et al. 2002. Involvement of p38 MAP kinase during iron chelator-mediated apoptotic cell death. Cell. Immunol. 220: 96-106. doi:10.1016/S0008-8749(03)00031- 5. PMID:12657244.
24. Krtolica, A., Krucher, N.A., and Ludlow, J.W. 1998. Hypoxia-induced pRB hypophosphorylation results from downregulation of CDK and upregulation of PP1 activities. Oncogene, 17: 2295-2304. doi:10.1038/sj.onc.1202159. PMID:9811460.
25. Laughner, E., Taghavi, P., Chiles, K., Mahon, P.C., and Semenza, G.L. 2001. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell Biol. 21 : 3995-4004. doi:10.1128/MCB.21.12.3995-4004.2001. PMID:11359907.
26. Le, N.T., and Richardson, D.R. 2002. The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim. Biophys. Acta, 1603: 31-46. PMID:12242109.
27. Lin, H.J., Hsieh, F.C., Song, H., and Lin, J. 2005. Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer. Br. J. Cancer, 93: 1372-1381. doi:10.1038/sj.bjc.6602862. PMID:16288304.
28. Lisztwan, J., Imbert, G., Wirbelauer, C., Gstaiger, M., and Krek, W. 1999. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes Dev. 13: 1822-1833. doi:10.1101/gad.13.14.1822. PMID:10421634.
29. Liu, X.H., Yu, E.Z., Li, Y.Y., Rollwagen, F.M., and Kagan, E. 2006. RNA interference targeting Akt promotes apoptosis in hypoxia-exposed human neuroblastoma cells. Brain Res. 1070: 24-30. doi:10.1016/j.brainres.2005. 11.041. PMID:16405925.
30. 2 induce caspase-3-independent degradation of Akt/protein kinase B. J. Biol. Chem. 277: 42943-42952. doi:10.1074/jbc.M201070200. PMID:12213802.
31. Masson, N., Willam, C., Maxwell, P.H., Pugh, C.W., and Ratcliffe, P.J. 2001. Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation. EMBO J. 20: 5197-5206. doi:10.1093/emboj/20.18.5197. PMID:11566883.
32. Matsui, T., Tao, J., del Monte, F., Lee, K.H., Li, L., Picard, M., et al. 2001. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation, 104: 330-335. PMID:11457753.
33. Maxwell, P.H., Wiesener, M.S., Chang, G.W., Clifford, S.C., Vaux, E.C., Cockman, M.E., et al. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature, 399: 271-275. doi:10.1038/20459. PMID:10353251.
34. Medina, E.A., Afsari, R.R., Ravid, T., Castillo, S.S., Erickson, K.L., and Goldkorn, T. 2005. Tumor necrosis factor-α decreases Akt protein levels in 3T3-L1 adipocytes via the caspase-dependent ubiquitination of Akt. Endocrinology, 146: 2726-2735. doi:10.1210/en.2004-1074. PMID:15746249.
35. Minchenko, O., Opentanova, I., and Caro, J. 2003. Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo. FEBS Lett. 554: 264-270. doi:10.1016/S0014-5793(03) 01179-7. PMID:14623077.
36. Mottet, D., Dumont, V., Deccache, Y., Demazy, C., Ninane, N., Raes, M., and Michiels, C. 2003. Regulation of hypoxia-inducible factor-1α protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/ glycogen synthase kinase 3β pathway in HepG2 cells. J. Biol. Chem. 278: 31277-31285. doi:10.1074/jbc.M300763200. PMID:12764143.
37. Nakatani, K., Sakaue, H., Thompson, D.A., Weigel, R.J., and Roth, R.A. 1999. Identification of a human Akt3 (protein kinase B γ) which contains the regulatory serine phosphorylation site. Biochem. Biophys. Res. Commun. 257: 906-910. doi:10.1006/bbrc.1999.0559. PMID:10208883.
38. Nicholson, D.W., Ali, A., Thornberry, N.A., Vaillancourt, J.P., Ding, C.K., Gallant, M., et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature, 376: 37-43. doi:10.1038/376037a0. PMID:7596430.
39. Oexle, H., Gnaiger, E., and Weiss, G. 1999. Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation. Biochim. Biophys. Acta, 1413: 99-107. doi:10.1016/S0005-2728(99)00088-2. PMID:10556622.
40. Okano, J., Gaslightwala, I., Birnbaum, M.J., Rustgi, A.K., and Nakagawa, H. 2000. Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation. J. Biol. Chem. 275: 30934-30942. doi:10.1074/jbc.M004112200. PMID: 10908564.
41. Papandreou, I., Krishna, C., Kaper, F., Cai, D., Giaccia, A.J., and Denko, N.C. 2005. Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. Cancer Res. 65: 3171-3178. PMID:15833847.
42. Renton, F.J., and Jeitner, T.M. 1996. Cell cycle-dependent inhibition of the proliferation of human neural tumor cell lines by iron chelators. Biochem. Pharmacol. 51: 1553-1561. doi:10.1016/0006-2952(96)00099-8. PMID:8630097.
43. Salceda, S., and Caro, J. 1997. Hypoxia-inducible factor 1alpha (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272: 22642-22647. doi:10.1074/jbc.272.36.22642. PMID: 9278421.
44. Sarbassov, D.D., Guertin, D.A., Ali, S.M., and Sabatini, D.M. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science, 307: 1098-1101. doi:10.1126/science.1106148. PMID:15718470.
45. Sarbassov, D.D., Ali, S.M., Sengupta, S., Sheen, J.H., Hsu, P.P., Bagley, A.F., et al. 2006. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell, 22: 159-168. doi:10.1016/j.molcel.2006.03.029. PMID:16603397.
46. Sasabe, E., Tatemoto, Y., Li, D., Yamamoto, T., and Osaki, T. 2005. Mechanism of HIF-1α-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells. Cancer Sci. 96: 394-402. doi:10.1111/j.1349-7006.2005.00065.x. PMID:16053510.
47. Schnitzer, S.E., Schmid, T., Zhou, J., Eisenbrand, G., and Brune, B. 2005. Inhibition of GSK3β by indirubins restores HIF-1α accumulation under prolonged periods of hypoxia/anoxia. FEBS Lett. 579: 529-533. doi:10.1016/j.febslet.2004.12.023. PMID:15642371.
48. Schwickert, G., Walenta, S., Sundfør, K., Rofstad, E.K., and Mueller-Klieser, W. 1995. Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res. 55: 4757-4759. PMID:7585499.
49. Semenza, G.L., and Wang, G.L. 1992. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12: 5447-5454. PMID:1448077.
50. Seo, Y.J., Koh, S.H., Kang, H.J., Shin, H.Y., Jeong, G., and Ahn, H.S. 2007. Hypoxia inhibits the SDF-1-dependent migration of human leukemic cell line HL-60 via blocking of Akt activation. Biochem. Biophys. Res. Commun. 364: 388-394. doi:10.1016/j.bbrc.2007.10.023. PMID:17950696.
51. Shinzawa, K., and Tsujimoto, Y. 2003. PLA2 activity is required for nuclear shrinkage in caspase-independent cell death. J. Cell Biol. 163: 1219-1230. doi:10.1083/jcb.200306159. PMID:14676306.
52. Sun, M., Wang, G., Paciga, J.E., Feldman, R.I., Yuan, Z.Q., Ma, X.L., et al. 2001. AKT1/PKBα kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am. J. Pathol. 159: 431-437. PMID:11485901.
53. Tanimoto, K., Makino, Y., Pereira, T., and Poellinger, L. 2000. Mechanism of regulation of the hypoxia-inducible factor-1 α by the von Hippel-Lindau tumor suppressor protein. EMBO J. 19: 4298-4309. doi:10.1093/emboj/19.16.4298. PMID:10944113.
54. Tokunaga, E., Kataoka, A., Kimura, Y., Oki, E., Mashino, K., Nishida, K., et al. 2006. The association between Akt activation and resistance to hormone therapy in metastatic breast cancer. Eur. J. Cancer, 42: 629-635. doi:10.1016/j.ejca.2005.11.025. PMID:16464571.
55. Tomida, A., and Tsuruo, T. 1999. Drug resistance mediated by cellular stress response to the microenvironment of solid tumors. Anticancer Drug Des. 14: 169-177. PMID:10405643.
56. Tracy, K., Dibling, B.C., Spike, B.T., Knabb, J.R., Schumacker, P., and Macleod, K.F. 2007. BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol. Cell Biol. 27: 6229-6242. doi:10.1128/MCB.02246-06. PMID:17576813.
57. Truttmann, A.C., Ashraf, Q., Mishra, O.P., and Delivoria-Papadopoulos, M. 2004. Effect of hypoxia on protein phosphatase 2A activity, subcellular distribution and expression in cerebral cortex of newborn piglets. Neuroscience, 127: 355-363. doi:10.1016/j.neuroscience.2004.05.033. PMID:15262326.
58. Ugi, S., Imamura, T., Maegawa, H., Egawa, K., Yoshizaki, T., Shi, K., et al. 2004. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Mol. Cell. Biol. 24: 8778-8789. doi:10.1128/MCB.24.19.8778- 8789.2004. PMID:15367694.
59. Van Kanegan, M.J., Adams, D.G., Wadzinski, B.E., and Strack, S. 2005. Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt. J. Biol. Chem. 280: 36029-36036. doi:10.1074/jbc. M506986200. PMID:16129692.
60. Wang, G.L., and Semenza, G.L. 1993a. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268: 21513-21518. PMID: 8408001.
61. Wang, G.L., and Semenza, G.L. 1993b. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood, 82: 3610-3615. PMID:8260699.
62. 2 tension. Proc. Natl. Acad. Sci. U.S.A. 92: 5510-5514. doi:10.1073/pnas.92.12.5510. PMID:7539918.
63. Yamaguchi, A., Tamatani, M., Matsuzaki, H., Namikawa, K., Kiyama, H., Vitek, M.P., et al. 2001. Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J. Biol. Chem. 276: 5256-5264. doi:10.1074/jbc.M008552200. PMID:11054421.
64. Zuluaga, S., Alvarez-Barrientos, A., Gutierrez-Uzquiza, A., Benito, M., Nebreda, A.R., and Porras, A. 2007. Negative regulation of Akt activity by p38α MAP kinase in cardiomyocytes involves membrane localization of PP2A through interaction with caveolin-1. Cell. Signal. 19: 62-74. doi:10.1016/j.cellsig.2006.05.032. PMID:16844343.